Literature DB >> 16507346

A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety.

Stephen P Whiteside1, John D Port, Brett J Deacon, Jonathan S Abramowitz.   

Abstract

The aim of the current study was to use proton magnetic resonance spectroscopy (MRS) to investigate potential irregularities in neurochemical compounds in obsessive-compulsive disorder (OCD) and the extent to which these irregularities are related to state anxiety. Single voxel MRS was used to image the head of the caudate nucleus (HOC) and orbitofrontal white matter (OFWM) bilaterally in adult patients with OCD and a control group. The results indicated that patients with OCD had increased levels of a combined measure of glutamate and glutamine (Glx/Cr) and N-acetyl-l-aspartic acid (NAA/Cr) relative to creatine in the right OFWM and reduced levels of myo-inositol relative to creatine (mI/Cr) in the HOC bilaterally. Correlational analyses indicated that Glx/Cr in the OFWM was related to OCD symptoms, while mI/Cr in the HOC was related to trait and/or state anxiety. Reanalysis of the significant group differences controlling for state anxiety symptoms erased three of the four group differences. These results are discussed in context of the methodological difficulties facing this area of research.

Entities:  

Mesh:

Year:  2006        PMID: 16507346     DOI: 10.1016/j.pscychresns.2005.12.006

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  38 in total

1.  Glutamate system genes associated with ventral prefrontal and thalamic volume in pediatric obsessive-compulsive disorder.

Authors:  Paul Daniel Arnold; Frank P Macmaster; Gregory L Hanna; Margaret A Richter; Tricia Sicard; Eliza Burroughs; Yousha Mirza; Phillip C Easter; Michelle Rose; James L Kennedy; David R Rosenberg
Journal:  Brain Imaging Behav       Date:  2009-03-01       Impact factor: 3.978

2.  An Examination of Rostral Anterior Cingulate Cortex Function and Neurochemistry in Obsessive-Compulsive Disorder.

Authors:  Brian P Brennan; Olga Tkachenko; Zachary J Schwab; Richard J Juelich; Erin M Ryan; Alison J Athey; Harrison G Pope; Michael A Jenike; Justin T Baker; William D S Killgore; James I Hudson; J Eric Jensen; Scott L Rauch
Journal:  Neuropsychopharmacology       Date:  2015-02-09       Impact factor: 7.853

3.  OCD candidate gene SLC1A1/EAAT3 impacts basal ganglia-mediated activity and stereotypic behavior.

Authors:  Isaac D Zike; Muhammad O Chohan; Jared M Kopelman; Emily N Krasnow; Daniel Flicker; Katherine M Nautiyal; Michael Bubser; Christoph Kellendonk; Carrie K Jones; Gregg Stanwood; Kenji Fransis Tanaka; Holly Moore; Susanne E Ahmari; Jeremy Veenstra-VanderWeele
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-15       Impact factor: 11.205

4.  Glutamate and the Treatment of Obsessive-Compulsive Disorder.

Authors:  Frank P Macmaster; David R Rosenberg
Journal:  Psychopharm Rev       Date:  2010-05-01

5.  1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: effects of 12 weeks of sertraline treatment on brain metabolites.

Authors:  Raşit Tükel; Kubilay Aydın; Erhan Ertekin; Seda Şahin Özyıldırım; Mehmet Barburoğlu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-26       Impact factor: 5.270

6.  Long-term outcome in adults with obsessive-compulsive disorder.

Authors:  Michael H Bloch; Christy Green; Stephen A Kichuk; Philip A Dombrowski; Suzanne Wasylink; Eileen Billingslea; Angeli Landeros-Weisenberger; Benjamin Kelmendi; Wayne K Goodman; James F Leckman; Vladimir Coric; Christopher Pittenger
Journal:  Depress Anxiety       Date:  2013-03-26       Impact factor: 6.505

Review 7.  Brain imaging in pediatric obsessive-compulsive disorder.

Authors:  Frank P MacMaster; Joseph O'Neill; David R Rosenberg
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-11       Impact factor: 8.829

8.  In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD).

Authors:  Mohammad Haghighi; Leila Jahangard; Hamid Mohammad-Beigi; Hafez Bajoghli; Hassan Hafezian; Alireza Rahimi; Hamid Afshar; Edith Holsboer-Trachsler; Serge Brand
Journal:  Psychopharmacology (Berl)       Date:  2013-03-23       Impact factor: 4.530

9.  Glutamate system genes and brain volume alterations in pediatric obsessive-compulsive disorder: a preliminary study.

Authors:  Ke Wu; Gregory L Hanna; Philip Easter; James L Kennedy; David R Rosenberg; Paul D Arnold
Journal:  Psychiatry Res       Date:  2012-11-13       Impact factor: 3.222

10.  Orbital frontal cortex in treatment-naïve pediatric obsessive-compulsive disorder.

Authors:  Frank Macmaster; Anvi Vora; Phillip Easter; Carrie Rix; David Rosenberg
Journal:  Psychiatry Res       Date:  2010-01-13       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.